Hormone therapy, including estrogen and progesterone treatments, is commonly used to manage symptoms of menopause, polycystic ovary syndrome (PCOS), and other hormonal imbalances. Variants in the CYP2C19 gene can influence how effectively a woman metabolizes these hormones, potentially impacting the therapy's effectiveness and safety.
